Although in and out a few times, recently buying at mostly 3+ makes me look better.Nothing at present seems to do justice to the sp. Hopefully some funding news (if we get that far) will be helpful.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025